Table 1.
Study design.
| Group | Number of mice | Type II collagen antibody injection | Daily P. gingivalis gavage |
|---|---|---|---|
| A | 7 | 7 mg Day 1, and 4 mg Day 5 | 1 through 15 days |
| B | 7 | None | 1 through 15 days |
| C | 7 | 7 mg Day 1, and 4 mg Day 5 | None |
| D | 7 | None | None |
| Total | 28 | ||
Study design.
| Group | Number of mice | Type II collagen antibody injection | Daily P. gingivalis gavage |
|---|---|---|---|
| A | 7 | 7 mg Day 1, and 4 mg Day 5 | 1 through 15 days |
| B | 7 | None | 1 through 15 days |
| C | 7 | 7 mg Day 1, and 4 mg Day 5 | None |
| D | 7 | None | None |
| Total | 28 | ||